UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism

Oncogene, 2010-04, Vol.29 (17), p.2577-2584

2010

Volltextzugriff (PDF)

Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma

British journal of cancer, 2009-10, Vol.101 (8), p.1357-1364

2009

Volltextzugriff (PDF)

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer

Oncogene, 2007-01, Vol.26 (2), p.290-297

2007

Volltextzugriff (PDF)

Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines

Oncology reports, 2002-09, Vol.9 (5), p.971

2002

Volltextzugriff (PDF)

Relationship between flow cytometry, oncogene amplications and cathepsin D in node negative (N−) breast carcinoma

Biology of the cell, 1992, Vol.76 (2), p.280-280

1992

Volltextzugriff (PDF)

Distinct expression of Survivin splice variants in breast carcinomas

International journal of oncology, 2005-10, Vol.27 (4), p.1151

2005

Volltextzugriff (PDF)

Expression of the gadd153 gene in normal and tumor breast tissues by a sensitive RT-PCR method

International journal of molecular medicine, 1999-11, Vol.4 (5), p.545

1999

Volltextzugriff (PDF)

Comparaison des altérations microsatellitaires dans une population de cancer du sein avant et après traitement par chimiothérapie première

Immuno-analyse & biologie spécialisée, 2004-10, Vol.19 (5), p.255-260

2004

Volltextzugriff (PDF)

Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers

The American journal of pathology, 1989-11, Vol.135 (5), p.847-855

1989

Volltextzugriff (PDF)

Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins

Cancer chemotherapy and pharmacology, 2002-06, Vol.49 (6), p.445-452

2002

Volltextzugriff (PDF)

Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer

Breast cancer research : BCR, 1999, Vol.1 (1), p.81-87, Article 81

1999

Volltextzugriff (PDF)

Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations

Cancer research (Chicago, Ill.), 2001-11, Vol.61 (21), p.7955-7958

2001

Volltextzugriff (PDF)

Breast carcinoma metastasis within granulosa cell tumor of the ovary: Morphologic, immunohistologic, and molecular analyses of the two different tumor cell populations

Human pathology, 2002-04, Vol.33 (4), p.445-448

2002

Volltextzugriff (PDF)

Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance

Bulletin du cancer, 2005-03, Vol.92 (3), p.219

2005

Volltextzugriff (PDF)

Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests

Bulletin du cancer, 1995-03, Vol.82 (3), p.211

1995

Volltextzugriff (PDF)

Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer

Breast cancer research and treatment, 2000-05, Vol.61 (1), p.13-20

2000

Volltextzugriff (PDF)

Abnormal Expression of Neurofilament Proteins in Ewing’s Sarcoma Cell Cultures

Tumor biology, 1992, Vol.13 (1-2), p.36-43

1992

Volltextzugriff (PDF)

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer

Oncogene, 2007-01, Vol.26 (2), p.290-297

2007

Volltextzugriff (PDF)

Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study

Cancer detection and prevention, 1995, Vol.19 (6), p.527

1995

Volltextzugriff (PDF)

Benign breast disease : absence of genetic alterations at several loci implicated in breast cancer malignancy

Cancer research (Chicago, Ill.), 1995-10, Vol.55 (19), p.4416-4419

1995

Volltextzugriff (PDF)

MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients

Anticancer research, 1999-07, Vol.19 (4C), p.3575

1999

Volltextzugriff (PDF)

Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node‐negative breast cancer

International journal of cancer, 1997-08, Vol.72 (4), p.599-603

1997

Volltextzugriff (PDF)

Immunohistological characterization of a Ewing's sarcoma case

Cancer detection and prevention, 1988, Vol.12 (1-6), p.297

1988

Volltextzugriff (PDF)

Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer

Archives of surgery (Chicago. 1960), 2003-03, Vol.138 (3), p.291

2003

Volltextzugriff (PDF)

201 Analysis of survivin splice variant transcripts in human breast tumor cells

European journal of cancer supplements, 2004-09, Vol.2 (8), p.62-62

2004

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(39)
Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Oncology
(26)
Biological And Medical Sciences
(23)
Breast Neoplasms - Genetics
(21)
Female
(21)
Medical Sciences
(21)
Breast Cancer
(15)
Tumors
(15)
Middle Aged
(14)
Gynecology. Andrology. Obstetrics
(13)
Mammary Gland Diseases
(12)
Breast Neoplasms - Pathology
(9)
Apoptosis
(8)
Breast Neoplasms - Drug Therapy
(8)
Breast Neoplasms - Metabolism
(8)
Loss Of Heterozygosity
(8)
Reverse Transcriptase Polymerase Chain Reaction
(8)
Tumor Cells, Cultured
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism

Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer

Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines

Relationship between flow cytometry, oncogene amplications and cathepsin D in node negative (N−) breast carcinoma

Distinct expression of Survivin splice variants in breast carcinomas

Expression of the gadd153 gene in normal and tumor breast tissues by a sensitive RT-PCR method

Comparaison des altérations microsatellitaires dans une population de cancer du sein avant et après traitement par chimiothérapie première

Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers

Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins

Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer

Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations

Breast carcinoma metastasis within granulosa cell tumor of the ovary: Morphologic, immunohistologic, and molecular analyses of the two different tumor cell populations

Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance

Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests

Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer

Abnormal Expression of Neurofilament Proteins in Ewing’s Sarcoma Cell Cultures

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer

Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study

Benign breast disease : absence of genetic alterations at several loci implicated in breast cancer malignancy

MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients

Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node‐negative breast cancer

Immunohistological characterization of a Ewing's sarcoma case

Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer

201 Analysis of survivin splice variant transcripts in human breast tumor cells

Suchergebnisse filtern